1988
DOI: 10.1002/jnr.490200411
|View full text |Cite
|
Sign up to set email alerts
|

GM1 ganglioside protects nucleus basalis from excitotoxin damage: Reduced cortical cholinergic losses and animal mortality

Abstract: Ten days after bilateral injections of ibotenic acid into the nucleus basalis, rats injected daily (i.m.) with ganglioside GM1 were protected from anterograde degeneration of cholinergic projections to the fronto-lateral cortex. This protection was reflected by reduced losses (associated with ibotenic acid lesions) of cortical acetylcholinesterase, choline acetyltransferase, and lowered animal mortality.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1988
1988
2015
2015

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 41 publications
(7 citation statements)
references
References 36 publications
0
7
0
Order By: Relevance
“…Based on their neural regenerative effect, gangliosides have been used successfully in animal models for the treatment of certain neurological disorders, such as diabetic neuropathy (18)(19)(20), and for acceleration of functional recovery after central nervous system damage (21)(22)(23) (24,25) and is capable of spontaneously differentiating or maturing to a benign ganglioneuroma (26 therefore agents that modify its activity might be of importance in the treatment of certain neuropathies and tumors, especially neuroblastomas.…”
Section: Resultsmentioning
confidence: 99%
“…Based on their neural regenerative effect, gangliosides have been used successfully in animal models for the treatment of certain neurological disorders, such as diabetic neuropathy (18)(19)(20), and for acceleration of functional recovery after central nervous system damage (21)(22)(23) (24,25) and is capable of spontaneously differentiating or maturing to a benign ganglioneuroma (26 therefore agents that modify its activity might be of importance in the treatment of certain neuropathies and tumors, especially neuroblastomas.…”
Section: Resultsmentioning
confidence: 99%
“…Gangliosides have been used successfully in animal models for the treatment of certain neurological disorders. The following beneficial effects have been reported for gangliosides: stimulation of the regeneration of the nervous system and facilitation of recovery after CNS damage [8], acceleration of reinnervation [9], facilitation of learning performance [10], decreased mortality after induction of global ischemia [11], counteraction of the slowing of nerve conduction in diabetic neuropathy [12], reduction of retrograde degeneration after neocortical lesions [13], protection against excitotoxin damage [14] and reduction of vincristineinduced neuropathy [15]. The findings reported here suggest that similar effects might be obtained by using specific inhibitors of protein kinase C.…”
Section: Resultsmentioning
confidence: 99%
“…These latter compounds have recently been reported to reduce glutamate and kainate toxicity (Favaron et a]., 1988) and anoxic neuronal death (Skaper et al ~ 1989) in cultured cerebellar granule cells, as well as direct excitotoxin damage in vivo (Mahadik et al, 1988;Lipartiti et al, 1989;Lombardi et al, 1989).…”
Section: Cell Culturementioning
confidence: 99%
“…Gangliosides represent a class of naturally occurring, sialic acid-containing glycosphingolipids (Svennerholm, 1963) highly concentrated in ncuronal plasma membranes (Ledeen, 1983). The administration of monosialogangliosides like GM 1 has been described to reduce glutamate and kainate neurotoxicity (Favaron et al, 1988) and anoxia-induced neuronal injury (Skaper et al, 1989) in cultured cerebcllar granule cells, and cxogemus excitotoxin damage in the CNS (Mahadik et al, 1988;Lipartiti et a]., 1989; Lombardi et a]., 1989). Ganglioside was examined here for an effect on glutamate receptor agonist-mediated retinal neuron injury.…”
Section: Effect Of Ganglioside Gm1 On Eaa-induced Retinal Neuronal Dementioning
confidence: 99%